Cellectis SA (CLLS)
1.43
+0.03
(+2.14%)
USD |
NASDAQ |
Oct 02, 16:00
1.41
-0.02
(-1.40%)
After-Hours: 20:00
Cellectis Enterprise Value : 81.43M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 81.43M |
| October 01, 2026 | 78.41M |
| September 30, 2026 | 89.49M |
| September 29, 2026 | 85.46M |
| September 28, 2026 | 86.47M |
| September 25, 2026 | 85.46M |
| September 24, 2026 | 81.43M |
| September 23, 2026 | 82.44M |
| September 22, 2026 | 94.52M |
| September 21, 2026 | 89.49M |
| September 18, 2026 | 91.50M |
| September 17, 2026 | 84.45M |
| September 16, 2026 | 75.90M |
| September 15, 2026 | 99.56M |
| September 14, 2026 | 121.71M |
| September 11, 2026 | 249.60M |
| September 10, 2026 | 251.61M |
| September 09, 2026 | 252.62M |
| September 08, 2026 | 255.64M |
| September 04, 2026 | 263.70M |
| September 03, 2026 | 271.75M |
| September 02, 2026 | 264.70M |
| September 01, 2026 | 269.74M |
| August 31, 2026 | 274.77M |
| August 28, 2026 | 279.81M |
| Date | Value |
|---|---|
| August 27, 2026 | 295.42M |
| August 26, 2026 | 281.82M |
| August 25, 2026 | 281.82M |
| August 24, 2026 | 258.66M |
| August 21, 2026 | 280.31M |
| August 20, 2026 | 286.86M |
| August 19, 2026 | 256.65M |
| August 18, 2026 | 243.56M |
| August 17, 2026 | 250.61M |
| August 14, 2026 | 244.56M |
| August 13, 2026 | 257.66M |
| August 12, 2026 | 233.49M |
| August 11, 2026 | 228.45M |
| August 10, 2026 | 215.36M |
| August 07, 2026 | 222.91M |
| August 06, 2026 | 208.31M |
| August 05, 2026 | 218.38M |
| August 04, 2026 | 216.37M |
| August 03, 2026 | 214.36M |
| July 31, 2026 | 214.36M |
| July 30, 2026 | 224.42M |
| July 29, 2026 | 225.43M |
| July 28, 2026 | 223.42M |
| July 27, 2026 | 228.45M |
| July 24, 2026 | 223.42M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| DBV Technologies SA | 411.48M |
| Akari Therapeutics Plc | 8.202M |
| Autolus Therapeutics Plc | 638.46M |
| Evaxion AS | 19.79M |
| Bicycle Therapeutics Plc | -324.57M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -21.79M |
| Revenue (Quarterly) | 5.222M |
| Total Expenses (Quarterly) | 27.01M |
| EPS Diluted (Quarterly) | -0.2165 |
| Gross Profit Margin (Quarterly) | 15.62% |
| Profit Margin (Quarterly) | -417.3% |
| Earnings Yield | -45.47% |
| Normalized Earnings Yield | -41.86 |